Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 | State
SAN FRANCISCO, CA / ACCESSWIRE / September 25, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the...
Jaguar
Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Jaguar Health, Inc. (NASDAQ:JAGX) has announced its participation in the Lytham Partners Fall 2024 Investor...
Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference | State
SAN FRANCISCO, CA / ACCESSWIRE / September 16, 2024 / Jaguar Health, Inc.(NASDAQ:JAGX) today announced that Lisa Conte, the company's...
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients
Jaguar Health (NASDAQ:JAGX) has announced an upcoming investor webcast on August 13, 2024, at 8:30...
